Delivery Order SPE2DB22D1017-SPE2DB25FE7KE

Award Date 10/17/24
Potential Completion Date 10/18/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for $1,727.08 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA). The contract is a Delivery Order issued under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC provides a comprehensive range of pharmaceutical and medical commodities, including specialty...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,389.38, is for the delivery of BUTALB-ACETAMIN-CAF-COD 50-300 100S, a pharmaceutical product, to support government healthcare programs. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025. This IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,096.11, is for the delivery of BUTALB-ACETAMIN-CAF-COD 50-300 100S, a pharmaceutical product, with a period of performance through November 28, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $1,474.20 with a firm fixed price and an ultimate completion date of February 21, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567331087 - BUTALB-ACETAMIN-CAFF 50-325-40 100S, a pharmaceutical product. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,306.93 firm fixed-price delivery order contract is for the supply of BUTALB-ACETAMIN-CAF-COD 50-300 100S medical products. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,132.58 firm fixed-price delivery order is for the supply of the drug "BUTALB-ACETAMIN-CAF-COD 50-300 100S" and has a completion date of June 6, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA), a major Defense agency, to Amerisourcebergen Drug Corp's Corporate Office division. The $1,347.36 Firm Fixed Price delivery order contract is for the supply of BUTALB-ACETAMIN-CAFF 50-325-40 500S pharmaceutical products. The award date is September 9, 2024, with an ultimate completion date of September 10, 2024. This is a child contract under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The contract covers the delivery of a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $999,999,999 through December 2025, enables the DLA to efficiently procure a comprehensive range of medical commodities, including prescription medications, medical supplies, and equipment, to support military treatment programs and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at $999,999,999, serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current delivery order, valued at $1,185.84, covers the procurement...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FE7KE
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The specific delivery order, valued at $1,240.93, is for the procurement of 4566133505 BUTALB-ACETAMIN-CAF-COD 50-300 100S, a medical product likely used for pain management. The contract has a firm fixed price pricing type and an ultimate completion date of October 18, 2024. The contract was awarded on October 17, 2024 and does not have a set-aside designation, indicating open competition.

Generated 1/16/25, 9:02 AM